ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables

Stock Information for Impact BioMedical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Impact BioMedical Inc.

ProPhase Labs to Present at the Investor Summit Virtual on March 11
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports
ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm
ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures
Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.